StocksFin Logo
Jazz Pharmaceuticals plc country of incorporation
|
|
Mr. Bruce Cozadd
|
3,200 employees
NASDAQ | Healthcare | Biotechnology
United Therapeutics Corporation country of incorporation
|
|
Dr. Martine Rothblatt
|
965 employees
NASDAQ | Healthcare | Biotechnology
Q322 reported Nov 9, 2022 Reporting Period
$940.65M 12.2% vs. Q321 Revenues Q322
85.79% 3.8% vs. Q321 Gross Profit Margin
-2.09% ! 66.9% vs. Q321 Net Profit Margin
422.89M 54.3% vs. Q321 Free Cash Flow Q322
$-0.31 ! 64% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Q322 reported Nov 2, 2022 Reporting Period
$516M 16% vs. Q321 Revenues Q322
92.79% -1% vs. Q321 Gross Profit Margin
46.38% 26.8% vs. Q321 Net Profit Margin
189.8M 2.3% vs. Q321 Free Cash Flow Q322
$5.26 45.3% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Loading...
Loading...
Loading...
Loading...
Ratios
As of
Sep 30, 2022
Sep 30, 2022
Quick Ratio
1.85
9.01
Current Ratio
3.16
9.68
Cash Ratio
1.03
3.06
Price to Book
3.05
2.09
Price to Sales
8.9
18.46
Price to Earnings
-106.48
9.95